Resources

A big raise as next generation biotech leaders gather, NHS England is abolished, and global trade disputes touch on our industry.

Maxion Therapeutics (”Maxion”), a biotechnology company developing antibody-based KnotBody® drugs for ion channel- and G protein coupled receptor (GPCR)-driven diseases, announced today that it has raised $72 million (£58 million) in a Series A financing.

Coulter Partners successfully completed a search assignment for ExpressionEdits and is pleased to announce the placement of Dr. Amrik Basran as Chief Scientific Officer (CSO).

The 2024 Bionow Awards dinner marked an exceptional evening of recognition and celebration, as 342 distinguished guests gathered at the Concorde Conference Centre on 6 March to honour those who have demonstrated outstanding ingenuity and dedication.

The Wilton Centre - one of 12 Pioneer Group sites - could provide the answer after a study highlighted the shortage of commercial laboratory space in the North East of England.

Innovate UK has announced an investment over £14 million across 29 innovative projects to help make the UK’s medicines manufacturing sector more sustainable.

Arecor establishes partnership with biopharmaceutical company to develop novel formulation of peptide therapy.

RoslinCT has entered into a strategic partnership with Gamida Cell Ltd. to manufacture their FDA-Approved Cell Therapy Omisirge.®

From Friday, 7 to Sunday, 16 March, British Science Week 2025 is a chance to celebrate everything about science and the amazing contributions made by professionals within this field. This year’s theme, “Change and Adapt,” encourages us to reflect on how humans, animals, and technology evolve to meet the challenges of a growing population and changing environment.

On 6 March 2025, just ahead of International Women’s Day, the BioIndustry Association (BIA) hosted the Women in Biotech Cambridge event—a vibrant gathering of trailblazing women shaping the life sciences landscape.

This week, BIA was invited by the Foreign Secretary to represent UK life sciences in Japan. In Parliament, we're championing a robust industrial strategy. Our new report provides the data and real life experience on womens’ leadership in our sector, while a former Board BIA member joins Duran Duran (sort of).

Gastronomica, the state-of-the-art food and drink incubator, officially launched at Pioneer Group’s Colworth Science Park on 5 March.

TRIMTECH Therapeutics raises $31 million seed funding to advance targeted protein degradation pipeline for treatment of neurodegenerative diseases.

Up to 70,000 new jobs will be needed in the UK life sciences sector over the next decade to unlock its potential in growing the UK economy, according to a new report.

New Women in Biotech leadership report is first in comprehensively collecting and examining C-suite gender leadership data for UK biotech. The report identifies clear successes of female leadership at the same time as highlighting sustained challenges.  

Stablepharma Ltd receives MHRA approval for Phase 1 trial of fridge-free tetanus and diphtheria (Td) vaccine.

Coulter Partners successfully completed a search assignment for Sensome and is pleased to announce the placement of Dr. Brian Burg as Chief Innovation Officer.

The UKHSA Conference 2025, delivered in partnership with the FPH, will explore the full breadth of UKHSA’s work; from science-driven research to effective policy implementation.

Last week was a big one for UK life sciences, from the BIA Committee Summit shaping our sector’s future to major leadership changes at UKRI and NHS England. In this week’s update, I explore what these developments mean for our industry, alongside breakthroughs in AI, investment, and accessibility in healthcare.